Diabetologia, 0012-186X
Journal
Related Publications
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
Heerspink, H. J. L., Perco, P., Mulder, S., Leierer, J., Hansen, M. K., Heinzel, A. & Mayer, G., Jul-2019, In : Diabetologia. 62, 7, p. 1154-1166 13 p.Research output: Contribution to journal › Article › Academic › peer-review
Blood Mg2+ is more closely associated with hyperglycaemia than with hypertriacylglycerolaemia: the PREVEND study
van Dijk, P. R., Schutten, J. C., Jeyarajah, E. J., Kootstra-Ros, J. E., Connelly, M. A., Bakker, S. J. L. & Dullaart, R. P. F., Sep-2019, In : Diabetologia. 62, 9, p. 1732-1734 3 p.Research output: Contribution to journal › Letter › Academic › peer-review
Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study (vol 59, pg 1963, 2012)
Abbasi, A., Corpeleijn, E., Meijer, E., Postmus, D., Gansevoort, R. T., Gans, R. O. B., Struck, J., Hillege, H. L., Stolk, R. P., Navis, G. & Bakker, S. J. L., Aug-2019, In : Diabetologia. 62, 8, p. 1518-1519 2 p.Research output: Contribution to journal › Article › Academic › peer-review
Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program
Matthews, D. R., Li, Q., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Desai, M., Hiatt, W. R., Nehler, M., Fabbrini, E., Kavalam, M., Lee, M. & Neal, B., Jun-2019, In : Diabetologia. 62, 6, p. 926-938 13 p.Research output: Contribution to journal › Article › Academic › peer-review
No availability, no uptake - exploring the reasons behind low uptake of insulin pump therapy in Irish adults with type 1 diabetes: findings from a national survey
Gajewska, K. A., Sreenan, S., Bennett, K. E., Gajewski, J. & Biesma, R., Oct-2018, In : Diabetologia. 61, Suppl.1, p. S426-S426 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
ID: 15741923